Inclusion on the list of medicines approved for hospital use.
-
Clinical Benefit
Substantial
The actual benefit of this medicinal product is substantial.
Clinical Added Value
moderate
BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children.
Listen
